Piedmont Research Center LLC Wilmington, NC - 28412

Piedmont Research Center LLC is categorized under Medical Research in Wilmington, NC and active since 2002.

Piedmont Research Center LLC was established in 2002, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.

If you are seeking more information, feel free to contact Beth Hollister at the company’s single location by writing to 3151 South 17th St, Wilmington, North Carolina NC 28412 or by phoning (910) 251-0081. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Piedmont Research Center LLC
Contact Person: Beth Hollister
Address: 3151 South 17th St, Wilmington, North Carolina 28412
Phone Number: (910) 251-0081
Website Address: ppdi.com
Annual Revenue (USD): $2.500.000 to $4.999.999
Founded: 2002
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Medical Research
SIC Code: 8733
NAICS Code: 541720
Share This Business:

Piedmont Research Center LLC was started in 2002 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact Beth Hollister for inquiries that concern Piedmont Research Center LLC by calling the company number (910) 251-0081, as your correspondence is most welcome. Additionally, the physical location of the single location of Piedmont Research Center LLC can be found at the coordinates 34.184395,-77.916446 as well as the street address 3151 South 17th St in Wilmington, North Carolina 28412.

For its online presence, you may visit Piedmont Research Center LLC’s website at ppdi.com and engage with its social media outlets through on Twitter and on Facebook.